Hsbc Holdings PLC Cure Vac N.V. Call Options Transaction History

Hsbc Holdings PLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 May 16, 2022	SELL	$14.73 - $35.25 $29,460 - $70,500	-2,000 Reduced 11.76%	15,000 $294,000
Q4 2021 Feb 11, 2022	BUY	$33.72 - $48.22 $185,460 - $265,210	5,500 Added 47.83%	17,000 $583,000
Q3 2021 Nov 12, 2021	SELL	$49.26 - $74.5 $123,150 - $186,250	-2,500 Reduced 17.86%	11,500 $628,000
Q2 2021 Aug 13, 2021	BUY	$56.91 - $127.53 $682,920 - $1.53 Million	12,000 Added 600.0%	14,000 $1.03 Million
Q1 2021 May 14, 2021	BUY	$79.79 - $126.29 $159,580 - $252,580	2,000 New	2,000 $182,000

12.3M

164K

117K

Ticker CVAC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,467,008
Market Cap $514M
Description
CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which ...

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

Stay updated on Hsbc Holdings PLC with notifications on news.